Creative approaches to improving access to medicines globally: Ideas from the hepatitis C experience

3 December 2019

Geneva, Switzerland

Access to medical products is a complex global challenge at the interface between health, economics, politics and development. This one-day symposium organised in collaboration with the Swiss Federal Institute of Intellectual Property and the Federal Office of Public Health focuses on a sub-set of access to medicines challenges, using Hepatitis C virus (HCV) as an extended case study to facilitate discussions and novel thinking.

Sessions

Expanding national treatment programmes

Moderator: Martina Schwab, Co-head, Global Health Section, Swiss Federal Office of Public Health

Speakers:

Philip Bruggmann, Chair Swiss Hepatitis, PD Dr. med., University of Zurich
Heba Wanis, Researcher, Third World Network
Gregory Dore, Professor, Kirby Institute, University of New South Wales,
Datuk Dr. Noor Hisham Abdullah, Director General of Health, Ministry of Health, Malaysia, and DNDi Board Member

Evolving innovation models and implications for access

Moderator: Lucas von Wattenwyl, Senior Advisor, Federal Institute of Intellectual Property

Speakers:

Victor Roy, Research Fellow, UCL Institute for Innovation and Public Purpose
Rekha Ramesh, Head of Global Public Policy, Gilead Sciences
Ari-Pekka Laitsaari, Expert in Growth Capital and Innovation Financing at the European Investment Bank
Bernard Pecoul, Executive Director, Drugs for Neglected Diseases initiative, Switzerland

More information: